v3.26.3
Earnings per share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Numerator:        
Net (loss) income from continuing operations $ (37,364) $ (54,250) $ 45,188 $ (152,415)
Less: excess redemption value above carrying value 0 (7,079) (381) (32,267)
Net (loss) income from continuing operations, net of excess redemption value (37,364) (61,329) 44,807 (184,682)
Net income (loss) from discontinued operations 4,643 (2,434) 4,381 (18,121)
Net (loss) income, net of excess redemption value (32,721) (63,763) 49,188 (202,803)
Less: Net income attributable to non-controlling interest 0 345 (16) 717
Net (loss) income attributable to Curaleaf Holdings, Inc., net of excess redemption value $ (32,721) $ (64,108) $ 49,204 $ (203,520)
Denominator:        
Basic weighted-average common shares outstanding (in shares) 264,882,536 254,941,874 262,168,678 252,936,604
Dilutive effect of contingent shares (in shares) 0 0 259,333 0
Dilutive weighted-average common shares outstanding (in shares) [1] 264,882,536 254,941,874 272,094,796 252,936,604
Per share — basic:        
Net (loss) income per share from continuing operations (in dollars per share) [2] $ (0.14) $ (0.24) $ 0.17 $ (0.73)
Net income (loss) per share from discontinued operations - basic (in dollars per share) 0.02 (0.01) 0.02 (0.07)
Net (loss) income per share attributable to Curaleaf Holdings, Inc.(in dollars per share) [2] (0.12) (0.25) 0.19 (0.80)
Per share - diluted :        
Net (loss) income per share from continuing operations (in dollars per share) [2] (0.14) (0.24) 0.16 (0.73)
Net income (loss) per share from discontinued operations - diluted (in dollars per share) [2] 0.02 (0.01) 0.02 (0.07)
Net (loss) income per share attributable to Curaleaf Holdings, Inc. (in dollars per share) [2] $ (0.12) $ (0.25) $ 0.18 $ (0.80)
Stock options        
Denominator:        
Dilutive effect of share-based payment arrangements (in shares) 0 0 1,855,899 0
Dilutive weighted-average common shares outstanding (in shares)     96,096  
Restricted and performance-based stock awards        
Denominator:        
Dilutive effect of share-based payment arrangements (in shares) 0 0 7,810,886 0
[1]
(2) As a result of the Company’s net loss for the three months ended September 30, 2026 and the three and nine months ended September 30, 2025, all potentially dilutive securities were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive. Accordingly, basic and diluted net loss per share are the same for each period presented.
[2]
(1) Certain non-controlling interests are redeemable at the option of the holders. Amounts recognized as accretion of redeemable non-controlling interests are recorded directly to shareholders' equity and reduce income available to subordinate voting shareholders in the calculation of earnings per share. The redeemable non-controlling interest was settled during the second quarter of 2026. The excess redemption value included in the EPS calculation for the nine months ended September 30, 2026 relates to accretion recognized through the settlement date. See Note 2 — Basis of presentation and consolidation and Note 24 — Earnings per share for additional information.